COMMUNIQUÉS West-GlobeNewswire

Anavar for Women: Exploring the Rise of Anvarol Performance Supplement Among Female Bodybuilders and Athletes From CrazyBulk
14/07/2025
Anavar for Women is trending in 2025 as fitness-focused women seek safer, effective cutting support. Discover how Anvarol is emerging as a leading legal alternative tailored for lean muscle tone, stamina, and strength— [...]
NTG Nordic Transport Group A/S - H1 2025 Conference Call
14/07/2025
NTG Nordic Transport Group A/S – H1 2025 Conference Call We expect to release the H1 2025 interim results of NTG Nordic Transport Group on the evening of August 11, 2025. A webcast and conference call will be held in [...]
OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025
14/07/2025
PRESS RELEASE OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025 OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including [...]
Menerals Launches in San Diego with Bold Mission to Restore Strength and Masculinity Through Real Nutrition
13/07/2025
New men’s health supplement brand introduces 100+ trace minerals to combat nutrient deficiency, testosterone decline, and performance burnout San Diego, CA, July 13, 2025 (GLOBE NEWSWIRE) -- Menerals, a new men’s health [...]
Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025
13/07/2025
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies Additional PALSONIFY presentations demonstrate [...]
Fat Burner For Men Launched Over the Counter in USA – PhenQ Medically Accredited Thermogenic Fat Burning Supplement for Men
13/07/2025
PhenQ 2025 OTC Fat Burner for Men: Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust. Glasgow, UK, July 13, 2025 (GLOBE NEWSWIRE) -- Introduction: Why PhenQ [...]
MSP Recovery Law Firm Secures Major Legal Win for MSP Recovery as Maryland Supreme Court Upholds Validity of Medicare Recovery Assignments for MSP Recovery and Its Healthcare Clients, Paving the Way for Medicare Recovery Rights Being Pursued Against GEICO
12/07/2025
MIAMI, July 12, 2025 (GLOBE NEWSWIRE) -- MSP Recovery Law Firm, counsel to MSP Recovery and its affiliated healthcare clients, announces a major legal victory following a decision by the Supreme Court of Maryland in the [...]
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
13/07/2025
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase 3 TRANSCEND study underscore potential efficacy of setmelanotide, including with [...]
Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq
11/07/2025
Profusa's Common Stock is Expected to Begin Trading on Nasdaq on Monday, July 14, 2025 Under the Ticker "PFSA" BERKELEY, Calif, July 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA [...]
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/07/2025
WOBURN, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of [...]
4DMT Announces New Employment Inducement Grants
11/07/2025
EMERYVILLE, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
11/07/2025
JENA, Germany, July 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it has [...]
Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
11/07/2025
Aliso Viejo, CA, July 11, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., the developer of the Life Backup Plan app, is issuing a clarification to our July 10, 2025 press release. Annette Slyman will not be joining the team in [...]
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
11/07/2025
Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are resolvable FDA clinical reviews acknowledged that the clinical data are robust and biomarker data [...]
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/07/2025
CAMBRIDGE, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with [...]
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
11/07/2025
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) has entered into an agreement with its largest warrant holder, amending the existing structure from [...]
Safest Steroid for Muscle Growth and Bodybuilding - Clinical Evidence and Safety Behind CrazyBulk's Bulking Steroids
11/07/2025
New York City, NY, July 11, 2025 (GLOBE NEWSWIRE) -- For decades, the use of muscle building steroids has been a driving force behind the pursuit of muscle growth and physical prowess among bodybuilders, athletes, and [...]
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants
11/07/2025
MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative [...]
Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion
11/07/2025
– Absence of neurotoxicity of any grade in low-volume disease to-date – – On track for first Biologics License Application (BLA) approved cell therapy in orphan indication relapsed/refractory AL Amyloidosis – – [...]

Pages